
Biovica International AB (publ) BIOVIC-B.ST
BIOVIC-B.ST
Biovica International AB (publ) CMOTEC-B.ST
Scandinavian ChemoTech AB (publ) BIOSGN.ST
Biosergen AB SCIB.ST
SciBase Holding AB (publ) NICA.ST
Nanologica AB (publ) HEART.ST
Scandinavian Real Heart AB (Publ) SPAGO.ST
Spago Nanomedical AB (publ) ATORX.ST
Alligator Bioscience AB (publ) NXTCL.ST
NextCell Pharma AB LPGO.ST
Lipigon Pharmaceuticals AB (publ)
Biovica International AB (publ) CMOTEC-B.ST
Scandinavian ChemoTech AB (publ) BIOSGN.ST
Biosergen AB SCIB.ST
SciBase Holding AB (publ) NICA.ST
Nanologica AB (publ) HEART.ST
Scandinavian Real Heart AB (Publ) SPAGO.ST
Spago Nanomedical AB (publ) ATORX.ST
Alligator Bioscience AB (publ) NXTCL.ST
NextCell Pharma AB LPGO.ST
Lipigon Pharmaceuticals AB (publ)
Performance
Periode | BIOVIC-B.ST | CMOTEC-B.ST | BIOSGN.ST | SCIB.ST | NICA.ST | HEART.ST | SPAGO.ST | ATORX.ST | NXTCL.ST | LPGO.ST |
---|---|---|---|---|---|---|---|---|---|---|
6M | -27.96 % | 218.24 % | 69.97 % | -9.33 % | 60.63 % | 93.38 % | 14.56 % | -48.57 % | 0.85 % | 44.36 % |
YTD | -71.26 % | 169.14 % | -7.43 % | -20.56 % | -21.98 % | 136.94 % | 14.56 % | -98.93 % | -62.68 % | 12.37 % |
1Y | -74.12 % | 144.04 % | -34.82 % | -32.67 % | -49.29 % | 19.55 % | 7.27 % | -99.77 % | -51.88 % | -28.07 % |
3Y | -93.94 % | -20.97 % | -74.06 % | -90.63 % | -85.61 % | -92.87 % | -69.67 % | -99.81 % | -88.58 % | -89.92 % |
5Y | -98.38 % | -57.76 % | -92.92 % | -90.91 % | -89.20 % | -90.78 % | -96.01 % | -99.97 % | -95.56 % | -98.67 % |
10Y | -95.21 % | -90.11 % | -92.92 % | -98.92 % | -91.87 % | -94.35 % | -98.50 % | -99.99 % | -66.14 % | -98.67 % |
Depuis le début | -95.21 % | -90.11 % | -92.92 % | -99.28 % | -91.87 % | -85.95 % | -97.99 % | -99.99 % | -66.14 % | -98.67 % |